PYRIDAZINONE COMPOUNDS AND USES THEREOF

(19)

(11)

EP 3 030 549 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	10.04.2019 Bulletin 2019/15

(45)	Mention of the grant of the patent:
	20.02.2019 Bulletin 2019/08

(21)	Application number: 14843298.2

(22)	Date of filing: 10.09.2014

(51)

International Patent Classification (IPC):

C07D 471/22^(2006.01)
C07D 487/22^(2006.01)
C07D 498/10^(2006.01)
C07D 498/22^(2006.01)
C07D 401/04^(2006.01)
C07D 401/10^(2006.01)
C07D 403/04^(2006.01)
C07D 403/08^(2006.01)
A61K 31/245^(2006.01)
A61K 31/501^(2006.01)

C07D 487/18^(2006.01)
C07D 498/08^(2006.01)
C07D 498/18^(2006.01)
C07D 519/00^(2006.01)
C07D 401/08^(2006.01)
C07D 401/12^(2006.01)
C07D 403/06^(2006.01)
A61K 45/06^(2006.01)
A61K 31/50^(2006.01)

(86)	International application number:
	PCT/US2014/055018

(87)	International publication number:
	WO 2015/038660 (19.03.2015 Gazette 2015/11)

(54)	PYRIDAZINONE COMPOUNDS AND USES THEREOF PYRIDAZINONVERBINDUNGEN UND VERWENDUNGEN DAVON COMPOSÉS DE PYRIDAZINONE ET LEURS UTILISATIONS

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME

(30)

Priority:

12.09.2013 US 201361877171 P

(43)	Date of publication of application:
	15.06.2016 Bulletin 2016/24

(73)	Proprietor: Janssen BioPharma, Inc.
	South San Francisco, CA 94080 (US)

(72)	Inventors:
	BEIGELMAN, Leonid South San Francisco, CA 94080 (US) HENDRICKS, Robert Than South San Francisco, CA 94080 (US) STOYCHEVA, Antitsa Dimitrova South San Francisco, CA 94080 (US) DEVAL, Jerome South San Francisco, CA 94080 (US) STEVENS, Sarah Katherine South San Francisco, CA 94080 (US)

(74)	Representative: Cornish, Kristina Victoria Joy et al
	Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL London WC1X 8NL (GB)

(56)

References cited: :

WO-A1-2010/090737
US-A1- 2009 281 107

WO-A1-2011/120153
US-A1- 2012 022 251

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).